Evidence map›Paper›PMID 27097326›Full record

ArticlePloS one2016

Comparative In Vivo Effects of Hemoglobin-Based Oxygen Carriers (HBOC) with Varying Prooxidant and Physiological Reactivity.

Vlad Al Toma, Anca D Farcaș, Ioana Roman, Bogdan Sevastre, Denisa Hathazi, Florina Scurtu, Grigore Damian, Radu Silaghi-Dumitrescu

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Oxidative medicine and cellular longevity · 2019
    Article
  8. Article
  9. Article
  10. Seven unconfirmed ideas to improve future ICU practice.Critical care (London, England) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vlad Al TomaBiological Research Institute, Cluj Napoca, 400113, Romania.
Anca D FarcașBiological Research Institute, Cluj Napoca, 400113, Romania.
Ioana RomanBiological Research Institute, Cluj Napoca, 400113, Romania.
Bogdan SevastreDepartment of Pathophysiology, University of Agricultural Sciences and Veterinary Medicine, Cluj Napoca, 400372, Romania.
Denisa HathaziDepartment of Chemistry and Chemical Engineering, Babes-Bolyai University, Cluj-Napoca, 400028, Romania.
Florina ScurtuDepartment of Chemistry and Chemical Engineering, Babes-Bolyai University, Cluj-Napoca, 400028, Romania.
Grigore DamianDepartment of Physics, Babes-Bolyai University, Cluj-Napoca, 400028, Romania.
Radu Silaghi-DumitrescuDepartment of Chemistry and Chemical Engineering, Babes-Bolyai University, Cluj-Napoca, 400028, Romania.
Babeș-Bolyai University · RONational Institute of Research and Development for Biological Sciences · ROUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of hemoglobin-based oxygen carrier candidates (HBOC), previously noted for their differences in prooxidative and physiological reactivity, were compared in terms of the negative effects displayed upon injection in Wistar rats. At the concentrations tested, antioxidant strategies based on albumin as well as based on rubrerythrin appear to offer observable physiological advantages.

Indexed as

AnimalsBlood CoagulationBlood GlucoseBlood SubstitutesCattleHematologic TestsHemoglobinsIronMaleOxidative StressRatsRats, WistarReactive Oxygen SpeciesTransferrinBlood GlucoseBlood SubstitutesHemoglobinsIronReactive Oxygen SpeciesTransferrin

Identifiers

PMID27097326
PMCPMC4838227
OpenAlexW2340724462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.